Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 7,806 | 6,827 | 7,101 | 6,918 | 6,002 |
| Operating Income | -7,806 | -6,827 | -7,101 | -6,918 | -6,002 |
| Interest Expense | 0 | 0 | 1 | 2 | 3 |
| Other Income | -256 | 131 | 503 | 296 | 1,601 |
| Pre-tax Income | -8,062 | -6,696 | -6,599 | -6,624 | -4,403 |
| Net Income Continuous | -8,062 | -6,696 | -6,599 | -6,624 | -4,403 |
| Net Income | $-8,062 | $-6,696 | $-6,599 | $-6,624 | $-4,403 |
| EPS Basic Total Ops | -4.20 | -3.60 | -4.20 | -4.20 | -3.00 |
| EPS Basic Continuous Ops | -4.33 | -3.64 | -4.16 | -4.28 | -2.99 |
| EPS Diluted Total Ops | -4.20 | -3.60 | -4.20 | -4.20 | -3.00 |
| EPS Diluted Continuous Ops | -4.33 | -3.64 | -4.16 | -4.28 | -2.99 |
| EBITDA(a) | $-7,785 | $-6,807 | $-7,081 | $-6,898 | $-5,984 |